Global Influenza Vaccine Market Analysis & Forecast Report 2024: Advanced R&D Initiatives Poised to Catalyze Growth Through 2034
January 31, 2024 09:18 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccine Market Analysis & Forecast 2024-2034: Market By Vaccine Type; By Indication; By Age Group; By Route of Administration; By...
FLUBLOK: A Quadrivalent Influenza Vaccine for Adults Aged 18 and Older - Drug Insights and Market Forecast to 2032
December 12, 2023 04:48 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "FLUBLOK QUADRIVALENT...
Fluzone Quadrivalent Drug Insights and Market Forecasts, 2019-2022 & 2023-2032
November 24, 2023 09:08 ET
|
Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers...
Seasonal Influenza Vaccines Market Report 2020: Flucelvax QIV and Flublok QIV are Expected to Experience Sales Growth Following Anticipated Regulatory Approvals in the EU in Q4 2020
December 04, 2020 03:58 ET
|
Research and Markets
Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The "Seasonal Influenza Vaccines" report has been added to ResearchAndMarkets.com's offering. The seasonal influenza vaccines market in the US, Japan, and...